Jupiter Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-195
| Closed | -$205K | – | 469 |
|
|
2024
Q3 | $205K | Buy |
+195
| New | +$205K | ﹤0.01% | 394 |
|
|
2024
Q1 | – | Sell |
-372
| Closed | -$327K | – | 512 |
|
|
2023
Q4 | $327K | Buy |
+372
| New | +$327K | ﹤0.01% | 430 |
|
|
2023
Q3 | – | Sell |
-19,964
| Closed | -$14.3M | – | 568 |
|
|
2023
Q2 | $14.3M | Sell |
19,964
-6,654
| -25% | -$4.78M | 0.16% | 173 |
|
|
2023
Q1 | $21.9M | Buy |
26,618
+2,625
| +11% | +$2.16M | 0.3% | 105 |
|
|
2022
Q4 | $17.3M | Buy |
+23,993
| New | +$17.3M | 0.25% | 131 |
|
|
2022
Q3 | – | Sell |
-36,217
| Closed | -$21.4M | – | 623 |
|
|
2022
Q2 | $21.4M | Buy |
+36,217
| New | +$21.4M | 0.3% | 102 |
|
|
2021
Q1 | – | Sell |
-26,626
| Closed | -$12.8M | – | 646 |
|
|
2020
Q4 | $12.8M | Buy |
26,626
+11,645
| +78% | +$5.62M | 0.13% | 192 |
|
|
2020
Q3 | $8.38M | Buy |
+14,981
| New | +$8.38M | 0.09% | 236 |
|